TESEVATINIB
In clinical trials for ADPKD. Wait for completion of trials. It increases serum creatinine (not usually a good thing in PKD), but while taking Tesevatinib this was thought to not effect PKD kidney functioning. New data demonstrated that serum creatinine levels in tesevatinib patients increased by 10% to 14% during the first 28 days of treatment and reversed upon treatment discontinuation.

↓ ARPKD
↓ ADPKD